On-Demand Webinar: Maximizing Clinical Trial Performance Using New Protocol Design Practices


Protocol design can have a significant impact on patient engagement and clinical trial performance. In this live webinar, explore the findings of a recent scholarly study conducted by the Center for the Study of Drug Development (CSDD) at Tufts University School of Medicine which characterize current protocol design practices and their effects on study volunteer experience and clinical trial performance.

Some of the topics that will be covered by our featured speaker include:
  • Benchmarks on industry-funded clinical trial protocol scope and structure
  • Overall and study-specific study timelines
  • Patient recruitment and retention rates
  • Study volunteer participation experience
  • New practices in protocol design
Finally, the speaker will provide insights on how small, medium and large sponsors can implement these new practices to optimize patient engagement, lower clinical cost and accelerate clinical trial speed.
Presented by
Ken Getz

Director of Sponsored Research Programs & Associate Professor, Tufts CSDD


Kenneth A. Getz is the director of Sponsored Research and an associate professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine. His research focuses on drug development management strategies and tactics; protocol design practices; and global outsourcing, investigative site and patient recruitment practices and policies. He is also the chairman and founder of The Center for Information and Study on Clinical Research Participation (CISCRP) – a nonprofit organization dedicated to educating and raising public and patient awareness of the clinical research enterprise.

A well-known speaker at conferences, symposia, universities, investor meetings and corporations, Ken has published extensively in peer-review journals, books and in the trade press and writes a bi-monthly column nominated for a Neal Award in Applied Clinical Trials. He holds a number of board appointments in the private and public sectors including WCG and ORA and serves on the editorial boards of Pharmaceutical Medicine and Therapeutic Innovation and Regulatory Science. Ken received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a Bachelor’s Degree from Brandeis University. Ken is the founder of CenterWatch, a leading publisher in the clinical trials industry.
Speaker Name
Speaker Title

Sed ac purus sit amet nisl tincidunt tincidunt vel at dolor. In ullamcorper nisi risus, quis fringilla nibh mattis ac. Mauris interdum interdum eros, eget tempus lectus aliquet at. Suspendisse convallis suscipit odio, ut varius enim lacinia in. Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Speaker Name
Speaker Title

Sed ac purus sit amet nisl tincidunt tincidunt vel at dolor. In ullamcorper nisi risus, quis fringilla nibh mattis ac. Mauris interdum interdum eros, eget tempus lectus aliquet at. Suspendisse convallis suscipit odio, ut varius enim lacinia in. Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Watch On Demand!